EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS
Abstract. In this study, we evaluated effects of statins and other biological preparations upon spontaneous and stimulated activation of МАРК p38 and ERK1/2 in monocytes from the patients with rheumatoid arthritis (RA). We used peripheral blood mononuclear cells (PBMC) from RA patients and healthy d...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/125341fdbf2044dfa262ffa6d2efc608 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:125341fdbf2044dfa262ffa6d2efc608 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:125341fdbf2044dfa262ffa6d2efc6082021-11-18T08:03:38ZEFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS1563-06252313-741X10.15789/1563-0625-2009-1-71-78https://doaj.org/article/125341fdbf2044dfa262ffa6d2efc6082014-07-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/190https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XAbstract. In this study, we evaluated effects of statins and other biological preparations upon spontaneous and stimulated activation of МАРК p38 and ERK1/2 in monocytes from the patients with rheumatoid arthritis (RA). We used peripheral blood mononuclear cells (PBMC) from RA patients and healthy donors. PBMC were cultured in presence of 0, 0.1, 1 or 10 мM mevastatin, 10 мg/ml IL-1 receptor antagonist (IL-1Ra), 5 мg/ml infliximab, and 5 мg/ml soluble pegylated p55 TNF-receptor (r-met-Hu-sTNF-RI). To study the mechanisms of mevastatin effects upon МАРК p38 and ERK1/2 activities, L-mevalonate was added to the cultures. The cells were stained with anti-phospho-MAPK p38, or anti-phospho-ERK1/2, and analyzed with flow cytometry. We have shown that IL-1Ra and r-met-Hu-sTNF-RI inhibited spontaneous MAPK р38 activation. Mevastatin reduced spontaneous MAPK p38 and ERK1/2 phosphorylation. Mevastatininduced suppression of MAPK p38 and ERK1/2 activation was not dose-dependent. L-mevalonate completely prevented mevastatin-induced reduction of MAPK р38 phosphorylation and partially reversed inhibition of МАРК ERK1/2. In conclusion, decrease in MAPK activation represents a common mechanism of anti-inflammatory effects exerted by statins and some other biologicals.I. V. ShirinskyV. A. KozlovV. S. ShirinskySPb RAACIarticlerheumatoid arthritismitogen-activated proteinkinasesstatinsbiologicalsImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 11, Iss 1, Pp 71-78 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
rheumatoid arthritis mitogen-activated proteinkinases statins biologicals Immunologic diseases. Allergy RC581-607 |
spellingShingle |
rheumatoid arthritis mitogen-activated proteinkinases statins biologicals Immunologic diseases. Allergy RC581-607 I. V. Shirinsky V. A. Kozlov V. S. Shirinsky EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
description |
Abstract. In this study, we evaluated effects of statins and other biological preparations upon spontaneous and stimulated activation of МАРК p38 and ERK1/2 in monocytes from the patients with rheumatoid arthritis (RA). We used peripheral blood mononuclear cells (PBMC) from RA patients and healthy donors. PBMC were cultured in presence of 0, 0.1, 1 or 10 мM mevastatin, 10 мg/ml IL-1 receptor antagonist (IL-1Ra), 5 мg/ml infliximab, and 5 мg/ml soluble pegylated p55 TNF-receptor (r-met-Hu-sTNF-RI). To study the mechanisms of mevastatin effects upon МАРК p38 and ERK1/2 activities, L-mevalonate was added to the cultures. The cells were stained with anti-phospho-MAPK p38, or anti-phospho-ERK1/2, and analyzed with flow cytometry. We have shown that IL-1Ra and r-met-Hu-sTNF-RI inhibited spontaneous MAPK р38 activation. Mevastatin reduced spontaneous MAPK p38 and ERK1/2 phosphorylation. Mevastatininduced suppression of MAPK p38 and ERK1/2 activation was not dose-dependent. L-mevalonate completely prevented mevastatin-induced reduction of MAPK р38 phosphorylation and partially reversed inhibition of МАРК ERK1/2. In conclusion, decrease in MAPK activation represents a common mechanism of anti-inflammatory effects exerted by statins and some other biologicals. |
format |
article |
author |
I. V. Shirinsky V. A. Kozlov V. S. Shirinsky |
author_facet |
I. V. Shirinsky V. A. Kozlov V. S. Shirinsky |
author_sort |
I. V. Shirinsky |
title |
EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
title_short |
EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
title_full |
EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
title_fullStr |
EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
title_full_unstemmed |
EFFECTS OF STATINS AND OTHER BIOLOGICAL PREPARATIONS UPON ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
title_sort |
effects of statins and other biological preparations upon activation of mitogen-activated protein kinases in patients with rheumatoid arthritis |
publisher |
SPb RAACI |
publishDate |
2014 |
url |
https://doaj.org/article/125341fdbf2044dfa262ffa6d2efc608 |
work_keys_str_mv |
AT ivshirinsky effectsofstatinsandotherbiologicalpreparationsuponactivationofmitogenactivatedproteinkinasesinpatientswithrheumatoidarthritis AT vakozlov effectsofstatinsandotherbiologicalpreparationsuponactivationofmitogenactivatedproteinkinasesinpatientswithrheumatoidarthritis AT vsshirinsky effectsofstatinsandotherbiologicalpreparationsuponactivationofmitogenactivatedproteinkinasesinpatientswithrheumatoidarthritis |
_version_ |
1718422526181244928 |